Loading…
Novo Nordisk announced plans to invest 8.5 billion Danish kroner to establish a new finished production facility and warehouse in Odense, Denmark. The site will cover over 40,000 m² and produce medicines for rare diseases like haemophilia. Construction has commenced and is scheduled to be completed in 2027, creating 400 permanent jobs.
“The investment marks the first time in this century that Novo Nordisk breaks ground in Denmark by establishing a new production site.”globenewswire.com
Summarized from public sources; check the original articles before acting on it.